LONG-TERM TRANSFER-FACTOR TREATMENT FOR MULTIPLE SCLEROSIS
- 1 April 1978
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 311 (8069), 851-853
- https://doi.org/10.1016/s0140-6736(78)90194-0
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- EFFECT OF PHYTOHEMAGGLUTININ, BASIC PROTEIN AND MEASLES ANTIGEN ON MYO-(2-3H)INOSITOL INCORPORATION INTO PHOSPHATIDYLINOSITOL OF LYMPHOCYTES FROM PATIENTS WITH MULTIPLE SCLEROSISActa Neurologica Scandinavica, 2009
- LYMPHOCYTE STIMULATION IN MULTIPLE SCLEROSIS PATIENTS UNTREATED AND TREATED WITH TRANSFER FACTORActa Neurologica Scandinavica, 2009
- LYMPHOCYTE STIMULATION IN MULTIPLE-SCLEROSIS PATIENTS UNTREATED AND TREATED WITH TRANSFER-FACTOR - LONG-TERM STUDIES ON EFFECT OF DIFFERENT STIMULANTS ON MYO-(2-H-3) INOSITOL INCORPORATION INTO PHOSPHATIDYLINOSITOL OF LYMPHOCYTES1977
- IMMUNOLOGICAL IN VITRO PARAMETERS IN PATIENTS WITH MULTIPLE SCLEROSIS AND IN NORMAL INDIVIDUALSActa Pathologica Microbiologica Scandinavica Section C Immunology, 1976
- TRANSFER-FACTOR THERAPY IN MULTIPLE SCLEROSISThe Lancet, 1976
- TRANSFER-FACTOR THERAPY IN MULTIPLE SCLEROSISThe Lancet, 1973
- HISTOCOMPATIBILITY DETERMINANTS IN MULTIPLE SCLEROSIS, WITH SPECIAL REFERENCE TO CLINICAL COURSEThe Lancet, 1973
- Immunoglobulin Abnormalities in Multiple SclerosisArchives of Neurology, 1973
- The frequency of relapse in multiple sclerosisZeitschrift für Neurologie, 1973